Asset Allocation for Dsp Healthcare Fund - Regular - Growth Fund Growth
Top 10 Holdings of Dsp Healthcare Fund - Regular - Growth Fund Growth
67.51 % of total assets
Sun Pharmaceutical Industries Limited(13.76%)
Cipla Limited(10.03%)
Lupin Limited(7.29%)
Suven Pharmaceuticals Limited(6.55%)
IPCA Laboratories Limited(6.05%)
Alembic Pharmaceuticals Limited(5.82%)
Apollo Hospitals Enterprise Limited(5.45%)
Procter & Gamble Health Limited(4.70%)
Alkem Laboratories Limited(4.15%)
Concord Biotech Limited(3.70%)
Detailed Portfolio of Dsp Healthcare Fund - Regular - Growth Fund Growth
Portfolio Date -31 Aug 2023
Equity Holdings -25
Other Holdings -3
| Holdings | % Weight | Value | Sahi Hai/Nahi |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited |
13.76% | 226.498 Cr | |
| Cipla Limited |
10.03% | 165.117 Cr | |
| Lupin Limited |
7.29% | 119.946 Cr | |
| Suven Pharmaceuticals Limited |
6.55% | 107.807 Cr | |
| IPCA Laboratories Limited |
6.05% | 99.614 Cr | |
| Alembic Pharmaceuticals Limited |
5.82% | 95.772 Cr | |
| Apollo Hospitals Enterprise Limited |
5.45% | 89.641 Cr | |
| Procter & Gamble Health Limited |
4.70% | 77.368 Cr | |
| Alkem Laboratories Limited |
4.15% | 68.356 Cr | |
| Concord Biotech Limited |
3.70% | 60.830 Cr | |
 Vijaya Diagnostic Centre Limited |
3.23% | 53.094 Cr | |
 Intuitive Surgical Inc |
2.95% | 48.519 Cr | - |
 Zydus Lifesciences Limited |
2.91% | 47.905 Cr | |
 Aarti Drugs Limited |
2.57% | 42.224 Cr | |
 Indoco Remedies Limited |
2.44% | 40.074 Cr | |
 Mankind Pharma Limited |
2.13% | 35.106 Cr | |
 ICICI Lombard General Insurance Company Limited |
1.93% | 31.714 Cr | |
 Kovai Medical Center and Hospital Limited |
1.87% | 30.767 Cr | |
| Globus Medical Inc |
1.82% | 29.969 Cr | - |
| Abbott Laboratories |
1.63% | 26.884 Cr | - |
| Taro Pharmaceutical Industries Limited |
1.38% | 22.758 Cr | - |
 Unichem Laboratories Limited |
1.35% | 22.199 Cr | |
 Medplus Health Services Limited |
0.95% | 15.585 Cr | |
| Illumina Inc |
0.70% | 11.475 Cr | - |
 Pfizer Limited |
0.35% | 5.824 Cr |
| Holdings | % Weight | Value | Sahi Hai/Nahi |
|---|---|---|---|
 TREPS / Reverse Repo Investments / Corporate Debt Repo |
3.28% | 53.907 Cr | - |
| Global X Funds - Global X Genomics & Biotechnology ETF |
1.12% | 18.477 Cr | - |
| Net Receivables/Payables |
-0.11% | -1.847 Cr | - |
Insight on the composition of the Dsp Healthcare Fund - Regular - Growth Fund Growth
Style Box of the Dsp Healthcare Fund - Regular - Growth Fund Growth
Portfolio Characteristics of the Dsp Healthcare Fund - Regular - Growth Fund Growth
